GHK-Cu vs PT-141
A comprehensive, data-driven comparison of GHK-Cu (Copper Peptide) and PT-141 (Bremelanotide). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | GHK-Cu Copper Peptide, GHK-Copper | PT-141 Bremelanotide, Vyleesi |
|---|---|---|
| FDA Status | Not submitted | FDA Approved |
| Category | Anti-Aging | Sexual Health |
| Primary Use | Skin rejuvenation and anti-aging | Hypoactive sexual desire disorder (HSDD) in women |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $150/mo | $800 - $1,200/mo |
| Administration | Topical | Subcutaneous injection |
| Typical Dose | 1-2% topical cream daily, or 1-2mg injection | 1.75mg as needed, at least 45 min before activity |
| Frequency | Daily | As needed |
| Mechanism | Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and has antioxidant properties | Melanocortin receptor agonist that activates central nervous system pathways involved in sexual arousal |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | High |
| Clinical Trial Phase | N/A | Approved |
Key Differences
- 1PT-141 is FDA-approved, while GHK-Cu is currently not submitted.
- 2GHK-Cu is generally more affordable ($30 - $150/mo) compared to PT-141 ($800 - $1,200/mo).
- 3GHK-Cu is administered via topical, while PT-141 uses subcutaneous injection.
- 4GHK-Cu is dosed daily, while PT-141 is as needed.
- 5PT-141 has high-quality evidence, while GHK-Cu has moderate-quality evidence.
- 6They belong to different categories: GHK-Cu (Anti-Aging) vs PT-141 (Sexual Health).
Which Is Better For...
PT-141
Those seeking an FDA-approved treatment with established safety data
GHK-Cu
More budget-friendly option with lower monthly costs
PT-141
More convenient dosing schedule (as needed)
GHK-Cu
Fewer commonly reported side effects
PT-141
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| GHK-Cu | $30 - $150/mo | Not submitted | Various research labs |
| PT-141 | $800 - $1,200/mo | FDA Approved | Cosette Pharmaceuticals (Covis Pharma) |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
GHK-Cu works via Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and. PT-141 works via Melanocortin receptor agonist that activates central nervous system pathways involved in sexual. They differ in FDA approval status, efficacy data, and cost.
GHK-Cu typically costs $30 - $150/mo, while PT-141 costs $800 - $1,200/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
GHK-Cu is not FDA-approved (Not submitted). PT-141 is FDA-approved. FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of GHK-Cu include Mild skin irritation (topical), Injection site reactions, Temporary copper taste. Common side effects of PT-141 include Nausea, Flushing, Injection site reactions. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
GHK-Cu is a naturally occurring copper-binding peptide found in human plasma that declines with age. It has been extensively studied for skin rejuvenation due to its ability to stimulate collagen and ...
View Full GHK-Cu GuidePT-141 (Bremelanotide) is an FDA-approved peptide medication marketed as Vyleesi for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike PDE5 inhibitors like Viagra, PT-14...
View Full PT-141 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between GHK-Cu and PT-141 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.